Previous close | 13.00 |
Open | 13.00 |
Bid | 17.40 |
Ask | 19.80 |
Strike | 230.00 |
Expiry date | 2024-12-20 |
Day's range | 13.00 - 13.00 |
Contract range | N/A |
Volume | |
Open interest | 110 |
GE HealthCare's (GEHC) new SIGNA MAGNUS can delve deep into the brain's microstructure, microvasculature and function, providing researchers with a clearer picture of neurological diseases and disorders.
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.